MDLZ
30
2
PGR
49
4
DVA
65
3
QRVO
18
2
REGN
44
2
CHRW
51
-2
BIIB
39
2
GIS
35
-12
HAL
30
-10
AMG
49
14
CI
38
3
PAYX
39
3
AON
28
2
WDC
40
3
FFIV
63
2
PFG
30
3
PEG
55
2
NEM
41
9
C
51
3
ISRG
66
2
MDLZ
30
2
PGR
49
4
DVA
65
3
QRVO
18
2
REGN
44
2
CHRW
51
-2
BIIB
39
2
GIS
35
-12
HAL
30
-10
AMG
49
14
CI
38
3
PAYX
39
3
AON
28
2
WDC
40
3
FFIV
63
2
PFG
30
3
PEG
55
2
NEM
41
9
C
51
3
ISRG
66
2
Financhill
Back

Brown & Brown Vs. Kymera Therapeutics Industry Stock Comparison

Buy
60

BRO
Brown & Brown

Last Price:
$103.68
Seasonality Move:
5.02%
Sell
39

KYMR
Kymera Therapeutics

Last Price:
$40.69
Seasonality Move:
2.79%
Buy
60
Brown & Brown (BRO) is a Buy

Is Brown & Brown a Buy, Sell or Hold?

  • The current Brown & Brown [BRO] share price is $102.80. The Score for BRO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • BRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Kymera Therapeutics (KYMR) is a Sell

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $40.79. The Score for KYMR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • KYMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BRO Stock Price Chart

What is Brown & Brown's stock price today?

  • The Brown & Brown share price today is $102.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BRO is experiencing buying pressure, which is a positive indicator for future bullish movement.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $40.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

BRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.85 Sell
Relative Strength Index (14 RSI): 37.26 Sell
Chaikin Money Flow: 588467 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.66 - 111.86) Sell
Bollinger Bands (100): (101.49 - 108.87) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.61 Sell
Relative Strength Index (14 RSI): 40.6 Sell
Chaikin Money Flow: 196490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.49 - 46.41) Sell
Bollinger Bands (100): (42.83 - 48.77) Sell

BRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.05 Sell
20-day SMA: 107.12 Sell
50-day SMA: 107.55 Sell
200-day SMA: 96.78 Buy
8-day EMA: 103.4 Sell
20-day EMA: 105.6 Sell
50-day EMA: 106.37 Sell
200-day EMA: 97.53 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.15 Sell
20-day SMA: 44.05 Sell
50-day SMA: 45.84 Sell
200-day SMA: 41.3 Sell
8-day EMA: 41.35 Sell
20-day EMA: 43.14 Sell
50-day EMA: 44.71 Sell
200-day EMA: 41.09 Sell

Brown & Brown Earnings Growth & BRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.34 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.37 per share.

Brown & Brown Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):